Advertisement
Screener

AgomAb Therapeutics NV (AGMB) SEC Comment Letters

2.8 / 5 stars · 68/120 Roast Me

AgomAb Therapeutics NV SEC Comment Letters

No SEC Comment Letters for AGMB on this site yet.

Source checked: its SEC EDGAR filings (CIK 2020932).